Medication info
Telmis Plus Tablet 80/25mg

Telmis Plus Tablet 80/25mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›25mg / 1 tablet
Manufacturer / importer
Samil Pharmaceutical Co., Ltd.
Appearance
Light yellow, biconvex round tablet
Packaging
30 tablets/box [(10 tablets/blister x 3)]
Approval status
Active

MFDS item code 201005770 · Notified 2010.09.30 · Insurance code 643902940

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a drink, regardless of meals, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, direct switching from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild-to-moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild-to-moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose change is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Samil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential Hypertension
View approved original text

This medication is used in patients with essential hypertension who do not achieve adequate blood pressure control with the combination or single-agent administration of Telmisartan 80mg and Hydrochlorothiazide 12.5mg. The two components work together to effectively lower and control blood pressure. This helps reduce the risk of cardiovascular complications and improve patient health.

How to take

Adult dose

Adults Take once daily with a drink, regardless of meals, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, direct switching from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild-to-moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild-to-moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose change is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can cause serious side effects to the fetus during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to any of the active ingredients or excipients of this medication should not take it, and those with hypersensitivity to sulfonamide drugs should also avoid use. Patients with severely impaired liver or kidney function, cholestatic diseases, pregnant or breastfeeding women should not take this medication. Elderly patients, those with high potassium levels, liver problems, or heart valve disease should use this medication with caution, particularly because there is an increased risk of skin cancer; therefore, it is essential to avoid sun exposure and regularly check skin conditions. This medication has blood pressure-lowering effects, so hypotensive symptoms may occur, and caution is advised if dizziness or fainting occurs. During the use of this medication, electrolyte levels in the blood should be regularly monitored to prevent and manage imbalances of potassium, sodium, magnesium, etc. When taken with other antihypertensive agents, lithium, various diuretics, anti-inflammatory drugs, etc., interactions may occur, so it must be taken carefully according to the doctor’s instructions. It should not be used during pregnancy or breastfeeding, and if pregnancy is planned, it is recommended to switch to a safer alternative medication. In the event of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, thus immediate consultation with healthcare professionals is necessary, and treatment should be tailored based on symptoms. It is not recommended for children, as its safety and efficacy have not been established, and careful administration should be considered for older adults to avoid excessive blood pressure-lowering effects. This medication should be stored out of reach of children and should be taken directly from sealed packaging just before use.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 112 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormality
  • hepatic impairment
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • lumbar pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • asthenia
  • increased blood creatinine
  • decreased hemoglobin
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • acute renal failure
  • diabetes
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • pneumonia
  • acute respiratory distress syndrome
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • lip and hand tremor
  • increased sensitivity
  • decreased vision
  • hypotension
  • tachycardia
  • nausea
  • hypersomnia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, biconvex round tablet

Package unit

30 tablets/box [(10 tablets/blister x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.